These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2379018)

  • 1. Reversible hyperpigmentation associated with high dose hydroxyurea.
    Majumdar G; Heard SE; Slater NG
    BMJ; 1990 Jun; 300(6737):1468. PubMed ID: 2379018
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin changes secondary to hydroxyurea therapy.
    Kennedy BJ; Smith LR; Goltz RW
    Arch Dermatol; 1975 Feb; 111(2):183-7. PubMed ID: 1054261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal melanonychia on multiple nails induced by hydroxyurea.
    Nguyen AL; Körver JE; Theunissen CC
    BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28202485
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of hydroxyurea-induced transverse melanonychia.
    Teo RY; Tan E
    Int J Dermatol; 2006 Nov; 45(11):1329-30. PubMed ID: 17076717
    [No Abstract]   [Full Text] [Related]  

  • 5. Longitudinal melanonychia induced by hydroxyurea: four case reports and review of the literature.
    Delmas-Marsalet B; Beaulieu P; Teillet-Thiebaud F; Jary L; Teillet F
    Nouv Rev Fr Hematol (1978); 1995; 37(3):205-10. PubMed ID: 7567439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal melanonychia in a patient with essential thrombocytosis under treatment with hydroxyurea.
    Clerico R; Corsetti P; Ambrifi M; Paolino G; Rossi MR; Bottoni U; Calvieri S
    Acta Dermatovenerol Croat; 2012; 20(4):281-3. PubMed ID: 23317494
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicoderma caused by hydroxyurea.
    Serrano-Falcón C; Pugnaire MAF; Del Mar Serrano-Falcón M; Morales MG; Serrano-Ortega S
    Int J Dermatol; 2011 Nov; 50(11):1435-1437. PubMed ID: 22004505
    [No Abstract]   [Full Text] [Related]  

  • 8. Images in clinical medicine. Acquired melanonychia.
    Ranta D; Bonmati C
    N Engl J Med; 2009 Sep; 361(12):1188. PubMed ID: 19759381
    [No Abstract]   [Full Text] [Related]  

  • 9. [Black discoloration of nails in polycythaemia vera].
    Konrad H; Wollina U
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):723-5. PubMed ID: 16173981
    [No Abstract]   [Full Text] [Related]  

  • 10. Nail pigmentation due to hydroxycarbamide.
    Ceulen RP; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review.
    Issaivanan M; Mitu PS; Manisha C; Praveen K
    Pediatr Dermatol; 2004; 21(2):124-7. PubMed ID: 15078351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.
    Zargari O; Kimyai-Asadi A; Jafroodi M
    Pediatr Dermatol; 2004; 21(6):633-5. PubMed ID: 15575845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leg ulcer in a patient associated with hydroxyurea therapy.
    Dissemond J; Hoeft D; Knab J; Franckson T; Kroger K; Goos M
    Int J Dermatol; 2006 Feb; 45(2):158-60. PubMed ID: 16445510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea-associated acral erythema in a patient with polycythemia vera.
    Butler D; Nambudiri VE; Nandi T
    Am J Hematol; 2014 Sep; 89(9):931-2. PubMed ID: 24585573
    [No Abstract]   [Full Text] [Related]  

  • 15. Minocycline-induced hyperpigmentation.
    Hung PH; Caldwell JB; James WD
    J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.
    O'branski EE; Ware RE; Prose NS; Kinney TR
    J Am Acad Dermatol; 2001 May; 44(5):859-61. PubMed ID: 11312437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective cutaneous hyperpigmentation in mice following zidovudine administration.
    Obuch ML; Baker G; Roth RI; Yen TS; Levin J; Berger TG
    Arch Dermatol; 1992 Apr; 128(4):508-13. PubMed ID: 1580658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transverse melanonychia and palmar hyperpigmentation secondary to hydroxyurea therapy.
    Schoenfeld J; Tulbert BH; Cusack CA
    Cutis; 2017 May; 99(5):E2-E4. PubMed ID: 28632807
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperpigmentation with daunorubicin therapy.
    Kelly TM; Fishman LM; Lessner HE
    Arch Dermatol; 1984 Feb; 120(2):262-3. PubMed ID: 6696484
    [No Abstract]   [Full Text] [Related]  

  • 20. [Longitudinal melanonychia and hydroxyurea].
    Pirard C; Michaux JL; Bourlond A
    Ann Dermatol Venereol; 1994; 121(2):106-9. PubMed ID: 7979014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.